Angelo Agathanggelou

4.8k citations

50 papers · 3.4k indexed · h-index 28

Co-authors: Farida Latif Eamonn R. Maher Gerald Niedobitek Wendy N. Cooper Lawrence S. Young Ashraf Dallol Sofia Honorio Tatjana Stanković
Topics: Epigenetics and DNA Methylation (12 papers)Chronic Lymphocytic Leukemia Research (11 papers)Viral-associated cancers and disorders (9 papers)
Cited by: Oncology Molecular Biology Cancer Research
Journals: The Lancet Blood Cancer Research
Partner nations: United Kingdom United States Germany

In The Last Decade

Angelo Agathanggelou

50 papers receiving 3.4k citations

Peers

Countries citing papers authored by Angelo Agathanggelou

Since Specialization

Citations

This map shows the geographic impact of Angelo Agathanggelou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Agathanggelou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Agathanggelou more than expected).

Fields of papers citing papers by Angelo Agathanggelou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Agathanggelou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Agathanggelou. The network helps show where Angelo Agathanggelou may publish in the future.

Co-authorship network of co-authors of Angelo Agathanggelou

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Agathanggelou. A scholar is included among the top collaborators of Angelo Agathanggelou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Agathanggelou. Angelo Agathanggelou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies 2024 ·Blood ·Marwan Kwok,Angelo Agathanggelou,Tatjana Stanković	7
2	Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity 2020 ·Tetrahedron ·(unknown),Xingjian Li,Louise Male,Tatjana Stanković,Angelo Agathanggelou,John Fossey	7
3	Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts 2017 ·Oncotarget ·Nicholas Davies,Marwan Kwok,(unknown),Ceri Oldreive,(unknown),Helen Parry,Edward Smith,Angelo Agathanggelou,Guy Pratt,A. Malcolm R. Taylor,Paul Moss,Mike Griffiths,Tatjana Stanković	10
4	ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells 2015 ·Blood ·Marwan Kwok,Nicholas Davies,Angelo Agathanggelou,Edward Smith,Ceri Oldreive,Eva Petermann,Grant S. Stewart,(unknown),Alan Lau,Guy Pratt,Helen Parry,A. Malcolm R. Taylor,Paul Moss,Peter Hillmen,Tatjana Stanković	211
5	Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway 2015 ·The Lancet ·Marwan Kwok,Nicholas Davies,Angelo Agathanggelou,Edward Smith,Eva Petermann,(unknown),Jeffrey S. Brown,Alan Lau,Tatjana Stanković	69
6	ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy 2014 ·Blood ·Marwan Kwok,Nicholas Davies,Angelo Agathanggelou,Edward Smith,Eva Petermann,(unknown),Jeffrey S. Brown,Alan Lau,Tatjana Stanković	1
7	Depletion of the Ras Association Domain Family 1, Isoform A–Associated Novel Microtubule-Associated Protein, C19ORF5/MAP1S, Causes Mitotic Abnormalities 2007 ·Cancer Research ·Ashraf Dallol,Wendy N. Cooper,Fahd Al‐Mulla,Angelo Agathanggelou,Eamonn R. Maher,Farida Latif	42
8	Involvement of the RASSF1A Tumor Suppressor Gene in Controlling Cell Migration 2005 ·Cancer Research ·Ashraf Dallol,Angelo Agathanggelou,Stella Tommasi,Gerd P. Pfeifer,Eamonn R. Maher,Farida Latif	76
9	Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma 2004 ·Oncogene ·Paul G. Murray,Guo‐Hua Qiu,Li Fu,(unknown),Gopesh Srivastava,(unknown),Angelo Agathanggelou,Farida Latif,Richard G. Grundy,Jillian R. Mann,Jane Starczynski,J Crocker,(unknown),Richard F. Ambinder,Lawrence S. Young,Qian Tao	49
10	Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours 2003 ·Oncogene ·Sofia Honorio,Angelo Agathanggelou,Nicolas Wernert,Marcus Rothe,Eamonn R. Maher,Farida Latif	93
11	Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers 2003 ·Oncogene ·Angelo Agathanggelou,Ashraf Dallol,Sabine Zöchbauer‐Müller,Catherine Morrissey,Sofia Honorio,Luke B. Hesson,Tommy Martinsson,Kwun M. Fong,Michael Kuo,Po Wing Yuen,Eamonn R. Maher,John D. Minna,Farida Latif	84
12	Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients 2003 ·Oncogene ·Sofia Honorio,Angelo Agathanggelou,Marcus Schuermann,Wulf Pankow,Paolo Viacava,Eamonn R. Maher,Farida Latif	100
13	RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours 2001 ·Oncogene ·Dewi Astuti,Angelo Agathanggelou,Sofia Honorio,Ashraf Dallol,Tommy Martinsson,Per Kogner,Carole Cummins,Hartmut P.H. Neumann,Raimo Voutilainen,Patricia L. M. Dahia,Charis Eng,Eamonn R. Maher,Farida Latif	108
14	Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours 2001 ·Oncogene ·Angelo Agathanggelou,Sofia Honorio,Donia Macartney‐Coxson,Alonso Martínez,Ashraf Dallol,Janet S. Rader,(unknown),(unknown),Rosemary A. Walker,Jacqui Shaw,Shigeto Hosoe,Michael I. Lerman,John D. Minna,Eamonn R. Maher,Farida Latif	336
15	Identification of a single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene 2001 ·Molecular and Cellular Probes ·Samuel Honório,Karl Gordon,(unknown),Angelo Agathanggelou,Farida Latif	2
16	EPSTEIN-BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV-INFECTED CELLS 1997 ·The Journal of Pathology ·Gerald Niedobitek,Angelo Agathanggelou,Hermann Herbst,Lucie Whitehead,Dennis H. Wright,Lawrence S. Young	165
17	Absence of Epstein-Barr virus in testicular germ cell tumours: a study of 21 cases using in situ hybridisation 1995 ·Molecular Pathology ·Nigel J. Trendell‐Smith,Angelo Agathanggelou,Hermann Herbst,C.M.P. Collins,Nicola J. Rooney,Gerald Niedobitek	3
18	Non‐Hodgkin's lymphoma, coeliac disease, and Epstein–Barr virus: A study of 13 cases of enteropathy‐associated T‐ and B‐cell lymphoma 1995 ·The Journal of Pathology ·Mohammad Ilyas,Gerald Niedobitek,Angelo Agathanggelou,R. E. Barry,A. E. Read,Rosemary J. Tierney,Lawrence S. Young,(unknown)	28
19	The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. 1995 ·PubMed ·Lucy Brooks,Gerald Niedobitek,Angelo Agathanggelou,Paul J. Farrell	10
20	P53 overexpression and Epstein‐Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas 1993 ·The Journal of Pathology ·Gerald Niedobitek,Angelo Agathanggelou,P.C. Barber,Lesley Smallman,E. L. Jones,Lawrence S. Young	75

About Angelo Agathanggelou

Angelo Agathanggelou is a scholar working on Genetics, Oncology and Otorhinolaryngology, having authored 50 papers that have together received 3.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Viral-associated cancers and disorders (9 papers). The work is most often cited by research in Oncology (1.3k citations), Molecular Biology (2.1k citations) and Cancer Research (447 citations). Angelo Agathanggelou has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Farida Latif, Eamonn R. Maher, Gerald Niedobitek, Wendy N. Cooper, Lawrence S. Young, Ashraf Dallol, Sofia Honorio, Tatjana Stanković, John M. Nicholls and Hermann Herbst. Their work appears in journals such as The Lancet, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact